Presentation is loading. Please wait.

Presentation is loading. Please wait.

Schematic representation of signaling by MCV large T antigen (T-Ag) and small t antigen (t-Ag). Schematic representation of signaling by MCV large T antigen.

Published byHeloísa Gomes Modified over 5 years ago

Similar presentations

Presentation on theme: "Schematic representation of signaling by MCV large T antigen (T-Ag) and small t antigen (t-Ag). Schematic representation of signaling by MCV large T antigen."— Presentation transcript:

1 Schematic representation of signaling by MCV large T antigen (T-Ag) and small t antigen (t-Ag).
Schematic representation of signaling by MCV large T antigen (T-Ag) and small t antigen (t-Ag). Targets for MCV T-Ag and t-Ag (center column) and biological effects (right column) are shown. ↑, upregulation; ↓, downregulation. pRb, retinoblastoma protein; Vam6p, vacuolar protein-sorting gene product; TLR9, Toll-like receptor 9; 4E-BP1, eukaryotic translation initiation factor 4E-binding protein 1; FBW7, F-box/WD repeat-containing protein 7; NEMO, NF-κB essential modulator. Martyn K. White et al. Clin. Microbiol. Rev. 2014; doi: /CMR

Download ppt "Schematic representation of signaling by MCV large T antigen (T-Ag) and small t antigen (t-Ag). Schematic representation of signaling by MCV large T antigen."

Similar presentations

Innate immune-signaling cascades and evidence for upregulation in brain following AIE exposure. Innate immune-signaling cascades and evidence for upregulation.

Innate immune-signaling cascades and evidence for upregulation in brain following AIE exposure. Innate immune-signaling cascades and evidence for upregulation.
Figure 1 Induction of immune tolerance

Figure 1 Induction of immune tolerance
Figure 4 Simplified T cell and antigen presenting

Figure 4 Simplified T cell and antigen presenting
Figure 1 CAR-T-cell design

Figure 1 CAR-T-cell design
Figure 1 A schematic representation of the HER2 signalling pathway

Figure 1 A schematic representation of the HER2 signalling pathway
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Volume 49, Issue 1, Pages 4-8 (January 2006)

Volume 49, Issue 1, Pages 4-8 (January 2006)
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Key airway signaling pathways induced by respiratory viruses.

Key airway signaling pathways induced by respiratory viruses.
Itraconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.

Itraconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.
Examples of immune response disruption by respiratory viruses.

Examples of immune response disruption by respiratory viruses.
Characterization of oprD promoter elements.

Characterization of oprD promoter elements.
Pathogenic schemes of diarrheagenic E. coli.

Pathogenic schemes of diarrheagenic E. coli.
Schematic diagram of the proposed structure of CFTR

Schematic diagram of the proposed structure of CFTR
Schematic representation of the HAV genome organization, translation products, and regions used for amplification. Schematic representation of the HAV.

Schematic representation of the HAV genome organization, translation products, and regions used for amplification. Schematic representation of the HAV.
Schematic representation of signaling by high-risk human papillomavirus HPV E7. Schematic representation of signaling by high-risk human papillomavirus.

Schematic representation of signaling by high-risk human papillomavirus HPV E7. Schematic representation of signaling by high-risk human papillomavirus.
Phylogenetic tree showing generic and species positions based on Bayesian analysis of the nuclear ribosomal DNA 28S region (1,200 bp) of Schistosomatidae.

Phylogenetic tree showing generic and species positions based on Bayesian analysis of the nuclear ribosomal DNA 28S region (1,200 bp) of Schistosomatidae.
Interaction of drug substrates and the AcrB-binding protomer analyzed with Autodock Vina docking software. Interaction of drug substrates and the AcrB-binding.

Interaction of drug substrates and the AcrB-binding protomer analyzed with Autodock Vina docking software. Interaction of drug substrates and the AcrB-binding.
Scheme of dynamic SCV development in the course from acute to chronic infection. Scheme of dynamic SCV development in the course from acute to chronic.

Scheme of dynamic SCV development in the course from acute to chronic infection. Scheme of dynamic SCV development in the course from acute to chronic.
Characteristics of the new family of telomeric Cryptosporidium proteins, Cops-1 and Chos-1. Characteristics of the new family of telomeric Cryptosporidium.

Characteristics of the new family of telomeric Cryptosporidium proteins, Cops-1 and Chos-1. Characteristics of the new family of telomeric Cryptosporidium.

Similar presentations

Ads by Google